“Positive Kidney Health”: Implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease-Reference-Cited by-同舟云学术

“Positive Kidney Health”: Implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease

Published:2023-03 Issue:2 Volume:63 Page:681-689
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Vu Amanda^ORCID,Nicholas Susanne B.^ORCID,Waterman Amy D.,Madievsky Ruth^ORCID,Cheng Felicia,Chon Janet,Fu Jeffery Y.^ORCID,Mangione Carol M.,Norris Keith C.^ORCID,Duru O. Kenrik

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference32 articles.

1. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease;Kidney Int,2020

2. Changes in the us burden of chronic kidney disease from 2002 to 2016: an analysis of the global burden of disease study;Bowe;JAMA Netw Open,2018

3. Effect of behavior modification on outcome in early- to moderate-stage chronic kidney disease: a cluster-randomized trial;Yamagata;PLoS One,2016

4. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Bikbov;Lancet,2020

5. CKD awareness among us adults by future risk of kidney failure;Chu;Am J Kidney Dis,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finerenone: Who Should Prescribe It for Chronic Kidney Disease? Nurse Practitioner Perspectives;The Journal for Nurse Practitioners;2024-07

2. Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States;Postgraduate Medicine;2024-05-11